This argues that the puzzling unevenness of human repair - where most organs are fragile and nonregenerative while the liver is highly regenerative - reflects an evolutionary tradeoff between regeneration and cancer risk. Examples include telomere shortening and restricted telomerase activity that limit cell division, the irreversible loss of neurons and many heart cells, common progressive failures like kidney scarring and gum recession, vulnerability to autoimmune diabetes and transplant rejection, and the rarity of menopause outside humans and a few whale and chimp populations. These features look like poor design only until framed as deliberate cancer-control mechanisms: suppressing widespread cell proliferation reduces the chance that mutant clones acquire immortality, at the cost of limited repair and accumulated “junk.”
The proposed theory is that evolution tunes organs’ regenerative capacity against their cancer tax. Tissues exposed directly to the environment - skin, gut, liver - face frequent damage and therefore evolve more turnover and a higher incidence of cancer; the liver’s role downstream of the gut, its toxic biochemistry, and its modular, repeat-unit architecture make regrowth feasible and necessary. Highly structured systems like the brain and heart cannot safely tolerate rampant cell replication without losing circuit integrity or immediate function, so they remain nonregenerative. The liver is exceptional because its function and structure favor paying the cancer cost to preserve organismal resilience.
Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.